best cryptocurrency under $1 to invest in 2021, Top

Poly Development: Poly Group increased its holdings by 261 million yuan. According to the announcement of Poly Development, the actual controller of the company, Poly Group, has completed the plan to increase its holdings, and accumulated 27,980,100 A shares, accounting for 0.23% of the total share capital, with an increase of 261 million yuan. This increase plan will last for 12 months from December 12, 2023, and the increase amount will be no less than 250 million yuan and no more than 500 million yuan. After the completion of the increase, Poly Group directly holds about 3.03% of the company's shares, and the total shareholding ratio with its wholly-owned subsidiaries is 40.72%. The increase in holdings is in compliance with relevant laws and regulations, and Poly Group promises not to reduce its holdings within the statutory time limit.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)US Treasury Secretary Yellen: The oil market is well supplied and the price is relatively low. US Treasury Secretary Yellen said that the oil market is well supplied and the price is relatively low. Russia has invested a lot of money in its fleet to avoid the western oil price cap sanctions.

Nordic United Bank: The risk of the European Central Bank cutting interest rates by 50 basis points cannot be ignored. Nordic United Bank said that the European Central Bank may cut interest rates by 25 basis points again, but there is also a significant risk of cutting interest rates by 50 basis points. The differences within the Committee have intensified again, and it is not easy for Lagarde to get another consistent compromise. A possible compromise is to cut interest rates by 25 basis points, and at the same time, some guidelines are given, indicating that as long as the ECB's benchmark view remains unchanged, it may cut interest rates again in January. Our benchmark expectation is still to cut interest rates by 25 basis points before the meeting in April next year, when the deposit interest rate is expected to reach 2.25%.Nordic United Bank: The risk of the European Central Bank cutting interest rates by 50 basis points cannot be ignored. Nordic United Bank said that the European Central Bank may cut interest rates by 25 basis points again, but there is also a significant risk of cutting interest rates by 50 basis points. The differences within the Committee have intensified again, and it is not easy for Lagarde to get another consistent compromise. A possible compromise is to cut interest rates by 25 basis points, and at the same time, some guidelines are given, indicating that as long as the ECB's benchmark view remains unchanged, it may cut interest rates again in January. Our benchmark expectation is still to cut interest rates by 25 basis points before the meeting in April next year, when the deposit interest rate is expected to reach 2.25%.Tschudin, member of the management Committee of the Swiss National Bank: Due to the monetary easing policy, Swiss economic growth is expected to pick up slightly next year. Overseas developments are the main risks facing the Swiss economy.

The second "Standards Week" of the National Network Security Standardization Technical Committee was held in Haikou in 2024, and the second "Standards Week" of the National Network Security Standardization Technical Committee (referred to as "Network Security Standardization Committee") was held in Haikou City, Hainan Province from December 8 to 11, 2024. Wang Jingtao, deputy director of the Central Network Information Office, deputy director of the National Network Information Office and chairman of the Network Security Standards Committee, pointed out that standards should help data security governance and supervision, speed up the development of standards such as data classification and classification protection requirements and compliance audit of personal information protection, and ensure the safe and orderly flow of data. It is necessary to lead the safe and orderly development of new technologies and applications such as artificial intelligence with standards and norms, accelerate the development and release of standards such as "Identification Method of Synthetic Content Generated by Artificial Intelligence", strengthen the research on relevant network security standards such as intelligent networked vehicles and autonomous driving, and effectively escort the safe development of emerging future industries.Zelensky's office stated that it was ready to negotiate with Russia. Mikhail Podolyak, adviser to the director of Ukrainian President Zelensky's office, said in an interview with Channel 24 that Kiev was ready to negotiate with Russia. He pointed out that simple solutions should not be expected, and Ukraine needs just peace conditions. Earlier, Kremlin spokesman dmitry Peskov said that Russia was willing to negotiate with Ukraine provided that the conditions proposed by Russian President Vladimir Putin were met. The conditions mentioned include the complete withdrawal of Ukrainian troops from new Russian regions and Ukraine's neutrality.The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)